Extracellular matrix in human diabetic nephropathy: Reduced expression of heparan sulphate in skin basement membrane

Diabetologia

Volumn 41, Issue 7, 1998, Pages 791-798

  Van Der Pijl, J W ^a   Daha, M R ^a   Van Den Born, J ^b   Verhagen, N A M ^a   Lemkes, H H P J ^a   Bucala, R ^c   Berden, J H M ^b   Zwinderman, A H ^d   Bruijn, J A ^a   Van Es, L A ^a   Van Der Woude, F J ^a,e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c PICOWER INST FOR MEDICAL RESEARCH   (United States)

^d LEIDEN UNIVERSITY   (Netherlands)

^e Department of Dermatology   (Germany)

Author keywords

Advanced glycosylation end products; Albuminuria; Basement membrane; Collagen; Diabetic nephropathy; Epidermodermal junction basement membrane zone; Fibroblasts; Heparitin sulphate; Skin; Type 1 diabetes mellitus

Indexed keywords

HEPARAN SULFATE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EXTRACELLULAR MATRIX; GLOMERULUS BASEMENT MEMBRANE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEINURIA;

ADULT; AGED; ALBUMINURIA; BASEMENT MEMBRANE; BIOPSY; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HEPARITIN SULFATE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; REFERENCE VALUES; RENAL REPLACEMENT THERAPY; SKIN;

EID: 15444355265     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050989     Document Type: Article

References (30)

1. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T (1983) Diabetic nephropathy in type I (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496-501
2. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A (1989) Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32: 219-226
3. Kanwar YS, Liu ZZ, Kashihara N, Wallner EI (1991) Current status of the structural and functional basis of glomerular filtration and proteinuria. Semin Nephrol 11: 390-413
4. van den Born J, van den Heuvel LPWJ, Bakker MAH, Veerkamp JH, Assmann KJM, Berden JHM (1992) A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats. Kidney Int 41: 115-123
5. Vernier RL, Steffes MW, Sisson-Ross S, Mauer SM (1992) Heparan sulfate proteoglycan in the glomerular basement membrane in type I diabetes mellitus. Kidney Int 41: 1070-1080
6. Tamsma JT, van den Born J, Bruijn JA et al. (1994) Expression of glomerular extracellular matrix components in human nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37: 313-320
7. Yokoyama H, Hoyer PE, Hansen PM et al. (1997) Immunohistochemical quantification of heparan sulfate proteoglycan and collagen IV in skeletal muscle capillary basement membranes of patients with diabetic nephropathy. Diabetes 46: 1875-1880
8. Wasty F, Alavi MZ, Moore S (1993) Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus. Diabetologia 36: 316-322
9. van Det NF, van den Born J, Tamsma JT et al. (1996) Effects of high glucose on the production of heparan sulfate proteoglycan by human mesangial and glomerular visceral epithelial cells in vitro. Kidney Int 49: 1079-1089
10. Gambaro G, Cavazzana AO, Luzzi P et al. (1992) Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int 42: 285-291
11. Gambaro G, Venturini AP, Noonan DM et al. (1994) Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy in the rat. Kidney Int 46: 797-806
12. Tamsma JT, van der Woude FJ, Lemkes HHPJ (1996) Effect of sulphated glycosaminoglycans on albuminuria in patients with overt (type I) nephropathy. Nephrol Dial Transplant 11: 182-185
13. Myrup B, Hansen PM, Jensen T et al. (1995) Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet 345: 421-422
14. van der Pijl JW, van der Woude FJ, Geelhoed-Duijvestijn PHLM et al. (1997) Danaparoid sodium lowers proteinuria in diabetic nephropathy. J Am Soc Nephrol 8: 456-462
15. van den Born J, van den Heuvel LPWJ, Bakker MAH et al. (1993) Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases. Kidney Int 43: 454-463
16. van den Heuvel LPWJ, van den Born J van de Velden TJAM et al. (1989) Isolation and partial characterization of heparan sulfate proteoglycan from human glomerular basement membrane. Biochem J 264: 457-465
17. Johansson C, Butkowski R, Wieslander J (1991) Characterization of monoclonal antibodies to the globular domain of collagen IV. Connect Tissue Res 25: 229-241
18. van Det NF, Tamsma JT, van den Born J et al. (1996) Differential effects of angiotensin II and transforming growth factor β on the production of heparan sulfate proteoglycan by mesangial cells in vivo. J Am Soc Nephrol 7: 1015-1023
19. Makita Z, Vlassara H, Cerami A, Bucala R (1992) Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 267: 5133-5138
20. van den Born J, van den Heuvel LPWJ, Bakker MAH, Veerkamp JH, Assmann KJM, Berden JHM (1994) Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: characterization and immunohistological application in human tissues. J Histochem Cytochem 42:89-102
21. Nakayama M, Kawaguchi Y, Yamada K et al. (1997) Immunohistochemical detection of advanced glycosylation endproducts in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 51: 182-186
22. Bruijn JA, Dinklo NJCM (1993) Distinct patterns of expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial-leukocyte adhesion molecule-1 in renal disease. Lab Invest 69: 329-335
23. van den Born J, Gunnarsson K, Bakker MA et al. (1995) Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J Biol Chem 270: 31303-31309
24. Kofoed-Enevoldsen A (1995) Heparan sulphate in the pathogenesis of diabetic nephropathy. Diabetes Metab Rev 11: 137-160
25. van den Born J, Berden JH (1995) Is microalbuminuria in diabetes due to changes in glomerular heparan sulphate? Nephrol Dial Transplant 10: 1277-1279
26. Nishino T, Horii Y, Shiiki H et al. (1995) Immunohistochemical detection of advanced glycosylation end products within the vascular lesions and glomeruli in diabetic nephropathy. Hum Pathol 26: 308-313
27. Beisswenger PJ, Makita Z, Curphey TJ et al. (1995) Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 44: 824-829
28. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462
29. Hanna W, Friesen D, Bombardier C, Gladmean D, Hanna A (1987) Pathologic features of diabetic thick skin. J Am Acad Dermatol 16: 546-553
30. Trevisan R, Yip J, Sarika L, Li LK, Viberti G (1997) Enhanced collagen synthesis in cultured skin fibroblasts from insulin-dependent diabetic patients with nephropathy. J Am Soc Nephrol 8: 1133-1139